The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Actiq 1600 micrograms compressed lozenge with integral oromucosal applicator



Teva Pharma B.V.PA0749/195/006

01 Jan 0001 - 01 Jan 000101 Jan 0001 - Present
« Back